Danske Bank has once again posted a record-breaking profit, reporting a post-tax surplus of 23.6 billion DKK for 2024 in its financial report for the last year. This is the best financial result ever ...
CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback